Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionSignet Financial Management, Llc
Latest Disclosed Ownership6,053 shares
Latest Disclosed Value $ 2,129,894
Signet Financial Management, Llc reports 1.71% decrease in ownership of AMGN / Amgen Inc.

On May 5, 2026 - Signet Financial Management, Llc filed a 13F-HR form disclosing ownership of 6,053 shares of Amgen Inc. (CH:AMGN) valued at $2,129,894 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 6,158 shares of Amgen Inc.. This represents a change in shares of -1.71% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AMGEN COM 031162100 6,053 -105 -1.71 2,130 5.66 0.2388
2026-01-08 2025-12-31 13F AMGEN COM 031162100 6,158 -25 -0.40 2,016 15.54 0.2253
2025-11-07 2025-09-30 13F AMGEN COM 031162100 6,183 -333 -5.11 1,745 -4.12 0.2026
2025-07-15 2025-06-30 13F AMGEN COM 031162100 6,516 -394 -5.70 1,819 -15.47 0.2285
2025-04-15 2025-03-31 13F AMGEN COM 031162100 6,910 -357 -4.91 2,153 13.68 0.2904
2025-01-13 2024-12-31 13F AMGEN COM 031162100 7,267 -347 -4.56 1,894 -22.83 0.2417
2024-10-23 2024-09-30 13F AMGEN COM 031162100 7,614 -369 -4.62 2,453 -1.64 0.3127
2024-08-02 2024-06-30 13F AMGEN COM 031162100 7,983 -171 -2.10 2,494 7.59 0.3365
2024-04-15 2024-03-31 13F AMGEN COM 031162100 8,154 741 10.00 2,318 8.57 0.3186
2024-01-30 2023-12-31 13F AMGEN COM 031162100 7,413 -175 -2.31 2,135 4.71 0.3197
2023-10-25 2023-09-30 13F AMGEN COM 031162100 7,588 -542 -6.67 2,039 12.96 0.3368
2023-07-18 2023-06-30 13F AMGEN COM 031162100 8,130 -286 -3.40 1,805 -11.26 0.2854
2023-04-17 2023-03-31 13F AMGEN COM 031162100 8,416 423 5.29 2,035 -3.10 0.3426
2023-02-14 2022-12-31 13F AMGEN COM 031162100 7,993 62 0.78 2,099 17.39 0.3749
2022-11-14 2022-09-30 13F AMGEN COM 031162100 7,931 303 3.97 1,788 -3.66 0.3499
2022-08-15 2022-06-30 13F AMGEN COM 031162100 7,628 966 14.50 1,856 15.21 0.3534
2022-05-13 2022-03-31 13F AMGEN COM 031162100 6,662 -29 -0.43 1,611 7.04 0.2695
2022-02-11 2021-12-31 13F AMGEN COM 031162100 6,691 -672 -9.13 1,505 -3.90 0.2279
2021-11-15 2021-09-30 13F AMGEN COM 031162100 7,363 7,363 1,566 0.2704
2021-08-09 2021-06-30 13F AMGEN COM 031162100 0 -7,112 -100.00 0 -100.00
2021-05-05 2021-03-31 13F AMGEN COM 031162100 7,112 368 5.46 1,769 14.06 0.3315
2021-02-10 2020-12-31 13F AMGEN COM 031162100 6,744 248 3.82 1,551 3.68 0.3136
2020-11-05 2020-09-30 13F AMGEN COM 031162100 6,496 -1,377 -17.49 1,496 -20.21 0.3308
2020-08-18 2020-06-30 13F AMGEN COM 031162100 7,873 456 6.15 1,875 6.59 0.4172
2020-05-20 2020-03-31 13F AMGEN COM 031162100 7,417 -484 -6.13 1,759 -7.66 0.4144
2020-01-23 2019-12-31 13F AMGEN COM 031162100 7,901 216 2.81 1,905 12.32 0.3556
2019-11-14 2019-09-30 13F AMGEN COM 031162100 7,685 113 1.49 1,696 27.71 0.3320
2019-08-13 2019-06-30 13F AMGEN COM 031162100 7,572 29 0.38 1,328 -0.23 0.2633
2019-05-15 2019-03-31 13F AMGEN COM 031162100 7,543 -977 -11.47 1,331 -19.77 0.2605
2019-02-14 2018-12-31 13F AMGEN COM 031162100 8,520 420 5.19 1,659 -1.19 0.3615
2018-11-14 2018-09-30 13F AMGEN COM 031162100 8,100 97 1.21 1,679 13.68 0.2936
2018-08-10 2018-06-30 13F AMGEN COM 031162100 8,003 -1,103 -12.11 1,477 -4.83 0.2605
2018-05-15 2018-03-31 13F AMGEN COM 031162100 9,106 -5 -0.05 1,552 -2.02 0.2791
2018-02-12 2017-12-31 13F AMGEN COM 031162100 9,111 -637 -6.53 1,584 -12.82 0.2949
2017-11-14 2017-09-30 13F AMGEN COM 031162100 9,748 80 0.83 1,817 9.06 0.3562
2017-08-14 2017-06-30 13F AMGEN COM 031162100 9,668 214 2.26 1,666 7.41 0.3521
2017-05-12 2017-03-31 13F AMGEN COM 031162100 9,454 108 1.16 1,551 13.54 0.3373
2017-02-10 2016-12-31 13F AMGEN COM 031162100 9,346 17 0.18 1,366 -12.21 0.3268
2016-11-14 2016-09-30 13F AMGEN COM 031162100 9,329 1,238 15.30 1,556 26.40 0.3664
2016-08-12 2016-06-30 13F AMGEN COM 031162100 8,091 2,707 50.28 1,231 52.54 0.2852
2016-05-16 2016-03-31 13F AMGEN COM 031162100 5,384 1,860 52.78 807 41.08 0.1702
2016-02-08 2015-12-31 13F AMGEN COM 031162100 3,524 -143 -3.90 572 12.82 0.1171
2015-11-13 2015-09-30 13F AMGEN COM 031162100 3,667 52 1.44 507 -8.65 0.1148
2015-08-13 2015-06-30 13F AMGEN COM 031162100 3,615 -19 -0.52 555 -4.48 0.1277
2015-05-14 2015-03-31 13F AMGEN COM 031162100 3,634 3,634 581 0.1609
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.